Related Experiment Videos
Dobutamine stress myocardial perfusion imaging
M L Geleijnse1, A Elhendy, P M Fioretti
1Thoraxcenter Rotterdam, University Hospital, Rotterdam-Dijkzigt, The Netherlands. ml.geleijnse@worldonline.nl
Insights
Dobutamine stress nuclear myocardial perfusion imaging (DSMPI) is a safe and effective alternative for detecting coronary artery disease (CAD) in patients unable to exercise. This non-exercise stress test accurately identifies CAD and helps assess patient prognosis.
Area of Science:
- Cardiology
- Nuclear Medicine
- Diagnostic Imaging
Background:
- Coronary artery disease (CAD) detection often requires stress testing.
- Patients with limited exercise capacity or contraindications to vasodilators need alternative stress modalities.
- Dobutamine stress nuclear myocardial perfusion imaging (DSMPI) offers an exercise-independent option.
Purpose of the Study:
- To evaluate the safety, efficacy, and prognostic value of DSMPI for detecting CAD.
- To compare DSMPI with other stress testing methods.
Main Methods:
- Systematic review and meta-analysis of 20 studies including 1,014 patients.
- Analysis of safety data from three reports totaling 2,574 patients.
- Comparison of DSMPI with dobutamine stress echocardiography and vasodilator myocardial perfusion imaging.
Main Results:
- DSMPI demonstrated high sensitivity (88%), specificity (74%), and accuracy (84%) for CAD detection.
- Excellent sensitivity for detecting one- (84%), two- (95%), and three-vessel disease (100%).
- Low rates of serious adverse events (0%) and excellent prognostic value ( < 1% annual hard event rate for normal scans).
Conclusions:
- DSMPI is a safe and effective non-exercise stress modality for CAD detection.
- The test provides valuable prognostic information, correlating perfusion defects with patient outcomes.
- DSMPI is a useful alternative for patients with contraindications to exercise or direct vasodilators.
Abstract:
In patients with limited exercise capacity and (relative) contraindications to direct vasodilators such as dipyridamole or adenosine, dobutamine stress nuclear myocardial perfusion imaging (DSMPI) represents an alternative, exercise-independent stress modality for the detection of coronary artery disease (CAD). Nondiagnostic test results (absence of reversible perfusion defects with submaximal stress) do occur in approximately 10% of patients. Serious side effects during DSMPI are rare, with no death, myocardial infarction or ventricular fibrillation reported in three DSMPI safety reports for a total of 2,574 patients. On the basis of a total number of 1,014 patients reported in 20 studies, the sensitivity, specificity and accuracy of the test for the detection of CAD were 88%, 74% and 84%, respectively. Mean sensitivities for one-, two- and three-vessel disease were 84%, 95% and 100%, respectively. The sensitivity for detection of left circumflex CAD (50%) was lower, compared with that for left anterior descending CAD (68%) and right CAD (88%). The sensitivity of predicting multivessel disease by multiregion perfusion abnormalities varied widely, from 44% to 89%, although specificity was excellent in all studies (89% to 94%). In direct diagnostic comparisons, DSMPI was more sensitive, but less specific, than dobutamine stress echocardiography and comparable with direct vasodilator myocardial perfusion imaging. In the largest prognostic study, patients with a normal DSMPI study had an annual hard event rate less than 1%. An ischemic scan pattern provided independent prognostic value, with a direct relationship between the extent and severity of the perfusion defects and prognosis. In conclusion, DSMPI seems a safe and useful nonexercise-dependent stress modality to detect CAD and assess prognosis.